Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: A new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry data

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 509-517

  Majolino, I ^a   Pearce, R ^a   Taghipour, G ^a   Goldstone, A H ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; FEMALE; HEMATOPOIESIS; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; STEM CELL TRANSPLANTATION;

EID: 0031028705     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.509     Document Type: Article

References (37)

1. Gratwohl A, Hermans J, Baldomero H: Hematopoietic precursor cell transplants in Europe: Activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 17:137-148, 1996
2. Kessinger A, Armitage JO, Smith DM, et al.: High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 74:1260-1265, 1989
3. Kessinger A, Armitage JO: The evolving role of peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77:211-213, 1991
4. Gale RP, Reiffers J, Juttner CA: What's new in blood progenitor cell autotransplants? Bone Marrow Transplant 14:343-346, 1994
5. To LB, Shepperd KM, Haylock DN, et al.: Single high-doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 18:442-447, 1990
6. Sheridan WP, Begley CG, Juttner CA, et al.: Effect of peripheral blood progenitor cells mobilised by G-CSF (filgrastim) on platelet recovery after high-dose chemotherapy. Lancet 339:640-644, 1992
7. Gianni AM, Siena S, Bregni M, et al.: Granulocyte-macrophage colony-stimulating factor to harvest circulating hemopoietic stem cells for autotransplantation. Lancet 2:580-585, 1989
8. Menichella G, Pierelli L, Foddai ML, et al.: Autologous blood stem cell harvesting and transplantation in patients with advanced ovarian cancer. Br J Haematol 79:444-450, 1991
9. To LB, Roberts MM, Haylock DN, et al.: Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 9:277-284, 1992
10. Henon PR, Liang H, Beck-Wirth G, et al.: Comparison of hemopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplant 9:285-291, 1992
11. Pierelli L, Iacone A, Quaglietta AM, et al.: Haemopoietic reconstitution after autologous blood stem cell transplantation in patients with malignancies: A multicentre retrospective study. Br J Haematol 86:70-75, 1994
12. Liberti G, Pearce R, Taghipour G, et al.: Comparison of peripheral and autologous bone marrow transplantation for lymphoma patients: A case-controlled analysis of the EBMT Registry data. Ann Oncol 5:151-153, 1994 (suppl 2)
13. Schwartzberg L, Birch R, Bianco R, et al.: Rapid and sustained hematopoietic reconstitution by peripheral blood stem cell infusion alone following high-dose chemotherapy. Bone Marrow Transplant 11:369-374, 1993
14. Weisdorf D, Daniels K, Miller W, et al.: Bone marrow vs. peripheral blood stem cells for autologous lymphoma transplantation: A prospective randomized trial. Blood 82:444, 1993 (abstr)
15. Indovina A, Majolino I, Buscemi F, et al.: Engraftment kinetics and long term stability of hematopoiesis following autografting of peripheral blood progenitor cells. Haematologica 88:115-122, 1995
16. Vose JM, Anderson JR, Kessinger A, et al.: High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. J Clin Oncol 11:1846-1851, 1993
17. Vose JM, Bierman PJ, Anderson JR, et al.: High-dose chemotherapy and autologous hematopoietic rescue for intermediate grade non-Hodgkin's lymphoma: Comparison of clinical outcome for patients receiving an autologous bone marrow (ABMT) or peripheral stem cell (PSCT) graft. Bordeaux, France, Third International Symposium on Peripheral Blood Stem Cell Autografts, October 11-13, 1993 (abstr)
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
19. Mantel N, Haenzel W: Statistical aspects of the analysis of data from the retrospective studies of disease. J Natl Cancer Inst 22:719-721, 1959
20. Cox DR: Regression models and life tables. J R Stat Soc [B]. 34:187-220, 1972
21. Majolino I, Quaglietta AM, Iacone A: Autologous blood stem cell transplantation in malignant lymphomas: An Italian Cooperative Group study. Leuk Lymphoma 7:11-16, 1992 (suppl)
22. Haas R, Möhle R, Frühauf S, et al.: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787-3794, 1994
23. Armitage JO, Bierman PJ, Vose JM, et al.: Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease. Am J Med 91:605-611, 1991
24. Reece DE, Connors JM, Spinelli JJ, et al.: Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy. Blood 83:1193-1199, 1994
25. Kessinger A, Bierman PJ, Vose JM, et al.: High-dose cyclophosphamide, carmustine and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease. Blood 11:2322-2325, 1991
26. Bartl R, Frissch B, Burkhardt R, et al.: Assessment of bone marrow histology in Hodgkin's disease: Correlation with clinical factors. Br J Haematol 51:345-360, 1982
27. Bierman P, Vose JM, Anderson J, et al.: Comparison of autologous bone marrow transplantation (ABMT) with peripheral stem cell transplantation (PSCT) for patients (PTS) with Hodgkin's disease (HD). St Louis, MO, 35th Annual Meeting of ASH, December 3-7, 1993 (abstr 1765)
28. Chopra R, Wotherspoon AC, Blair S, et al.: Detedtion and significance of bone marrow infiltration at the time of autologous bone marrow transplantation in Hodgkin's disease. Br J Haematol 87:647-649, 1994
29. Reiffers J, Labopin M, Sanz M, et al.: Autologous blood stem cell transplantation (ABSCT) versus bone marrow transplantation (ABMT) for patients with acute myeloid leukemia (AML) in first complete remission: A retrospective analysis of the EBMT Registry. Harrogate, UK, 20th Annual Meeting of the EBMT, March 13-17, (abstr n373)
30. Shpall EJ, Jones RB: Release of tumor cells from bone marrow (editorial). Blood 83:623-625, 1994
31. Moss, Sanders DG, Lasky LC, et al.: Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 76:1879-1883, 1990
32. Sharp JG, Kessinger A, Vaughan WP, et al.: Detection and clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. Int J Cell Clon 10:92-94, 1992
33. Gribben JG, Neuberg D, Barber M, et al.: Detection of residual lymphoma cells by polimerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800-3807, 1994
34. Brugger W, Bross KJ, Glatt M, et al.: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636-640, 1994
35. Gribben JG, Freedman AS, Neuberg D, et al.: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525-1533, 1991
36. Rill DR, Santana VM, Robert WM, et al.: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380-383, 1994
37. Williams CD, Goldstone AH, Pearce RM, et al.: Purging of bone marrow in ABMT for Non-Hodgkin's lymphoma: A case-matched comparison with unpurged cases by the EBMT Lymphoma Registry. J Clin Oncol 14:2454-2464, 1996